Schizophrenia News

New York Gov. Andrew Cuomo recently announced that the New York State Office of Mental Health is expanding the OnTrackNY program, which provides mental health services to young adults with newly emerging schizophrenic symptoms.

Automated speech analysis may be able to identify individuals who will progress to psychosis, according to study findings in npj Schizophrenia.

Cannabis use in adolescence moderated the association between genetic risk for schizophrenia and cortical maturation among males, according to study findings in JAMA Psychiatry.

Individuals with schizophrenia exhibited increased lactic acid levels in throat samples compared with healthy controls, suggesting utility of the oropharyngeal microbiome in distinguishing schizophrenia.

Exposure to psychotropic drugs during pregnancy increases risk for negative outcomes among infants, so much so that researchers recommend the population be considered high-risk.

Assessing retinal changes may aid clinicians in assessing schizophrenia risk and disease progression, according to study findings in Schizophrenia Research: Cognition.

Researchers identified biomarkers of suicidal ideation across multiple psychiatric disorders and developed an application to help clinicians accurately screen for suicide risk.

Thalamic dysconnectivity, similar to that observed in patients with schizophrenia, was observed among individuals at high risk for psychosis and was more pronounced among those who eventually progressed to a psychosis diagnosis, and was associated with symptom severity.

Otsuka Pharmaceutical, Inc. and Lundbeck recently announced the FDA expanded the label of Abilify Maintena for extended-release injectable suspension for schizophrenia to include the deltoid arm muscle.

An iPad game may improve episodic memory and functioning among patients with schizophrenia, according to study findings in Philosophical Transactions of the Royal Society B.